Bayer awaits Supreme Court decision on whether to overturn Monsanto Roundup glyphosate cancer verdicts as it wins third defense case in a row

Credit: Daniel Acker/Bloomberg
Credit: Daniel Acker/Bloomberg

Bayer won a jury verdict over Roundup on [June 9], the third defense win in a row over Monsanto’s pesticide. A jury in Jackson County Circuit Court in Kansas City, Missouri, found that Monsanto was not liable for Allan Shelton’s non-Hodgkin lymphoma.

Shelton, of Kansas City, Missouri, alleged he was diagnosed with cancer in his 20s after spraying Roundup at his home.

[Bayer, which acquired Monsanto in 2018] won Roundup verdicts last year in California: one on Oct. 5 in Los Angeles County Superior Court, and another on Dec. 9 in San Bernardino County Superior Court.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

“The jury’s verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer and was not the cause of Mr. Shelton’s cancer,” Bayer said in a statement. “These conclusions are consistent with the assessments of expert regulators worldwide as well as the overwhelming evidence from four decades of scientific studies concluding that Roundup can be used safely and is not carcinogenic.”

In 2018 and 2019, juries in San Francisco County Superior Court and Alameda County Superior Court, as well as U.S. District Court for the Northern District of California, awarded a total of nearly $2.4 billion in verdicts to Roundup plaintiffs.

[More Roundup trials are planned this year, including one in Missouri involving four plaintiffs that begins jury selection on Sept. 28.]

Bayer… has petitioned the U.S. Supreme Court to overturn one of the verdicts, for $80 million, arguing that federal law preempts the plaintiff’s claims. [If successful, all verdicts against Bayer could eventually be overturned.]

This is an excerpt. Read the original post here (behind paywall)

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.